Sitemap
January 23, 2006 Articles
Filter by Available Specialty
- Inspire discontinues macular edema drug trials
- Novartis posts record results for 2005; asserts CIBA is not for sale
- Pfizer ophthalmics unit posts $1.37 billion in revenue during 2005
- Positioning, graft placement vital to medial PF ligament reconstruction
- Updated crystalens has square edge, new injector
- Virologist: New antivirals needed in ophthalmic pipeline